These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28181275)

  • 1. Preparation of clinical-scale
    Guleria M; Das T; Kumar C; Amirdhanayagam J; Sarma HD; Banerjee S
    J Labelled Comp Radiopharm; 2017 May; 60(5):234-241. PubMed ID: 28181275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of Procedures for the Preparation of (177)Lu- and (90)Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation.
    Wojdowska W; Karczmarczyk U; Maurin M; Garnuszek P; Mikołajczak R
    Curr Radiopharm; 2015; 8(1):62-8. PubMed ID: 25506704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of
    Guleria M; Amirdhanayagam J; Sarma HD; Rallapeta RP; Krishnamohan VS; Nimmagadda A; Ravi P; Patri S; Kalawat T; Das T
    Biomed Res Int; 2021; 2021():1555712. PubMed ID: 34845436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
    Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
    Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with ⁹⁰Y and ¹¹¹In for domestic radioimmunotherapy and radioscintigraphy of non-Hodgkin's lymphoma.
    Gholipour N; Jalilian AR; Khalaj A; Johari-Daha F; Yavari K; Sabzevari O; Khanchi AR; Akhlaghi M
    Daru; 2014 Jul; 22(1):58. PubMed ID: 25074720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of DOTA-Chelators on the Antitumor Activity of
    Wojdowska W; Karczmarczyk U; Balog L; Sawicka A; Pöstényi Z; Kovács-Haász V; Polyák A; Laszuk E; Mikołajczak R; Garnuszek P
    Cancer Biother Radiopharm; 2020 Oct; 35(8):558-562. PubMed ID: 32255676
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study.
    Guleria M; Das T; Kumar C; Sharma R; Amirdhanayagam J; Sarma HD; Dash A
    Anticancer Agents Med Chem; 2018; 18(1):146-153. PubMed ID: 28745238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of therapeutic dose of 177Lu-DOTA-TATE using a novel single vial freeze-dried kit: a comparison with 'in-situ' preparation at hospital radiopharmacy.
    Das T; Banerjee S; Shinto A; Kamaleshwaran KK; Sarma HD
    Curr Radiopharm; 2014; 7(1):12-9. PubMed ID: 24934713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.
    Wu Y; Zhu H; Zhang B; Liu F; Chen J; Wang Y; Wang Y; Zhang Z; Wu L; Si L; Xu H; Yao T; Xiao S; Xia Q; Zhang L; Yang Z; Zhou D
    Bioconjug Chem; 2016 Oct; 27(10):2460-2468. PubMed ID: 27617674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and biological studies of ¹⁷⁷Lu-DOTA-rituximab for the treatment of Non-Hodgkin's lymphoma.
    Massicano AV; Pujatti PB; Alcarde LF; Suzuki MF; Spencer PJ; Araújo EB
    Curr Radiopharm; 2016; 9(1):54-63. PubMed ID: 25771373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
    Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
    Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of
    Pandey U; Kameswaran M; Gamre N; Dash A
    J Labelled Comp Radiopharm; 2019 Apr; 62(4):158-165. PubMed ID: 30663095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
    Forrer F; Chen J; Fani M; Powell P; Lohri A; Müller-Brand J; Moldenhauer G; Maecke HR
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1443-52. PubMed ID: 19350237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of patient dose of [
    Amirdhanayagam J; Guleria M; Sharma R; Kumar N; Mukherjee A; Das T
    J Labelled Comp Radiopharm; 2024 Apr; 67(4):131-144. PubMed ID: 38342496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
    Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
    Weber T; Bötticher B; Mier W; Sauter M; Krämer S; Leotta K; Keller A; Schlegelmilch A; Grosse-Hovest L; Jäger D; Haberkorn U; Arndt MA; Krauss J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):489-98. PubMed ID: 26341366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.
    Thakral P; Singla S; Yadav MP; Vasisht A; Sharma A; Gupta SK; Bal CS; ; Malhotra A
    Indian J Med Res; 2014 Apr; 139(4):544-54. PubMed ID: 24927340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy.
    Mukherjee A; Lohar S; Dash A; Sarma HD; Samuel G; Korde A
    J Labelled Comp Radiopharm; 2015 Apr; 58(4):166-72. PubMed ID: 25765604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and
    Altai M; Westerlund K; Velletta J; Mitran B; Honarvar H; Karlström AE
    Nucl Med Biol; 2017 Nov; 54():1-9. PubMed ID: 28810153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of [
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Nucl Med Biol; 2019; 78-79():31-40. PubMed ID: 31731177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.